share_log

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga ·  Feb 23 21:06

Gainers

  • Enveric Biosciences (NASDAQ:ENVB) shares increased by 83.5% to $1.56 during Friday's pre-market session. The company's market cap stands at $4.2 million.
  • Telesis Bio (NASDAQ:TBIO) stock increased by 34.53% to $0.62. The company's market cap stands at $18.4 million.
  • Maravai LifeSciences (NASDAQ:MRVI) shares moved upwards by 27.78% to $6.53. The company's market cap stands at $863.1 million. As per the press release, Q4 earnings came out yesterday.
  • Ocean Biomedical (NASDAQ:OCEA) shares increased by 23.75% to $0.68. The market value of their outstanding shares is at $23.1 million.
  • Nexalin Technology (NASDAQ:NXL) stock increased by 19.35% to $0.37. The market value of their outstanding shares is at $2.6 million.
  • OneMedNet (NASDAQ:ONMD) shares moved upwards by 15.18% to $0.9. The company's market cap stands at $29.0 million.

Losers

  • Venus Concept (NASDAQ:VERO) stock fell 24.2% to $1.41 during Friday's pre-market session. The company's market cap stands at $7.7 million.
  • Biophytis (NASDAQ:BPTS) shares fell 15.24% to $0.45. The company's market cap stands at $4.3 million.
  • Kazia Therapeutics (NASDAQ:KZIA) shares declined by 14.8% to $0.26. The company's market cap stands at $6.7 million.
  • ModivCare (NASDAQ:MODV) shares declined by 12.13% to $38.55. The market value of their outstanding shares is at $546.8 million. As per the news, the Q4 earnings report came out yesterday.
  • Ardelyx (NASDAQ:ARDX) stock declined by 11.91% to $7.77. The market value of their outstanding shares is at $1.8 billion. The company's, Q4 earnings came out yesterday.
  • Rigel Pharmaceuticals (NASDAQ:RIGL) stock decreased by 10.01% to $1.17. The market value of their outstanding shares is at $204.0 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment